Cleveland.com: Ventilator shortage during coronavirus? 3-D printing could save lives
UC anesthesiologist discusses ventilators
Imagine printing a three-dimensional piece of plastic that could help save a coronavirus patient’s life. 3-D printing is one solution proposed to address an expected shortage of ventilators, machines that keep patients whose lungs are severely damaged alive. Experts are expecting a shortages of ventilators as the number of people impacted by the coronavirus pandemic grows in the U.S.
Ventilators work through a breathing tube inserted into a person’s windpipe. The machine inflates the lungs with air and then deflates the lungs, removing carbon dioxide. A medical professional uses a computer to control the amount of pressure placed on the lungs and the amount of oxygen.
Coronavirus patients are at risk of pneumonia and acute respiratory distress syndrome, which has a high mortality rate. Dr. Suzanne Bennett, an associate professor at the UC College of Medicine and an anesthesiologist at UC Health, discussed the workings of ventilators.
A traditional ventilator costs about $25,000 to $50,000. Bennett said some of the “bells and whistles" on a hospital-grade ventilator help medical professionals operate the machine effectively, and reduce the workload for respiratory therapists. With a shortage, respiratory therapists would be spread thin.
“I think all of us are concerned with the safety of that patient in that situation,” she said.
Related Stories
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
Student-designed AI platform aims to match patients to specific cancer support groups
December 5, 2025
The University of Cincinnati is launching a clinical trial testing a student-designed, machine-learning powered platform to match patients with cancer to support groups specifically tailored to their needs and concerns.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.